SIRIC ILIAD 2023-2027
Organized around a research-care continuum, ILIAD brings together medical, scientific, and technological expertise while combining different disciplines.
ILIAD relies on integrated, innovative, and multidisciplinary research to detect, treat, and ensure sustainable employment for high-risk patients. Centered around the care pathway, the research conducted by ILIAD teams also focuses on patients’ life paths, incorporating issues of social inequalities and employment retention in the face of illness.
The research programs are implemented on two selected tumors as demonstrators: multiple myeloma and breast cancer.
![SIRIC ILIAD Nantes Angers](https://www.siric-iliad.com/wp-content/uploads/2024/02/sigle-Siric-ILIAD-2024.webp)
Predict and characterize high-risk patients.
Develop early detection of high-risk patients to tailor treatments and offer personalized therapies.
![](https://www.siric-iliad.com/wp-content/uploads/2024/01/pictos-decor.webp)
NEWS
A look back at … the Cancer and Work Meeting
REWORK: A toolbox to facilitate the return to work
SIRIC ILIAD is proud to count Philippe Moreau as one of the most influential researchers in the world 2022
Modeling tumor development and progression: From PDXs to cancer organoids | A colloquium sponsored by SIRIC ILIAD
New AF3M newsletter: AIDES & RIGHTS
![](https://www.siric-iliad.com/wp-content/uploads/2024/01/bulles-decor.webp)